Clinical trial
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular…
NCT00101764 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00101764 |
|---|---|
| Title | Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders |
| Official title | Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Retinal Vein Occlusion, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Triamcinolone Acetonide |
| Enrollment | 120 |
| Start date | Jan 5, 2005 |
| Completion | May 20, 2008 |
| First posted | Jan 13, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: